For example, high plasma levels of osteopontin (OPN) correlate with advanced fibrosis progression[153], and a similar trend was also observed in patients with NAFLD[154] and chronic HBV-induced fibrosis[136]. The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatotic liver disease.